Tingsn Launches China's First Domestically Developed 8F Intracardiac Echocardiography Catheter, Advancing Precision in Cardiac Interventions

In cardiac interventional therapy, intracardiac echocardiography (ICE) technology acts as a "navigation device." Through a miniature transducer at the tip of a catheter, it enters the heart via the femoral vein, enabling high-resolution real-time imaging of the heart and enhancing surgical precision. However, this technology has long been monopolized by imports, with high costs posing a "bottleneck" challenge.

TINGSN Confronts Challenges Head-On, Shouldering the Responsibility of Independent Innovation in China's Medical Technology. The company has gathered a top-tier research team, continuously increased R&D investment, and after countless experiments and optimizations, finally broke through technical bottlenecks, leading to the successive approval and market launch of multiple products. The recently approved TINGSN Sonic Eyes 8 Eco features an ultra-thin 8F (approximately 2.67mm) catheter design, significantly improving vascular passage compared to 10F catheters. Equipped with a self-developed 64-element micro-ultrasound transducer, it achieves multi-angle observation of cardiac anatomy and imaging with millimeter-level resolution through rotation and four-way controlled bending.This product is compatible with the TINGSN FINDERS 1 portable ultrasound diagnostic device, forming a "plug-and-play" mobile diagnosis and treatment system. It is widely applicable for intraoperative guidance in interventional procedures such as atrial fibrillation radiofrequency ablation, left atrial appendage closure, and congenital heart disease closure. It assists doctors in real-time monitoring of catheter positioning and complication surveillance, effectively enhancing the safety and success rate of surgeries.

The successful approval of the 8F intracardiac echocardiography catheter this time is the inevitable result of TINGSN's years of dedication and continuous innovation. As early as November 2023, TINGSN, with its "TINGSN Sonic Eyes 10," became the first company in China to independently develop and receive approval for a high-end intracardiac echocardiography diagnostic catheter, breaking the nearly 20-year monopoly of imported products and establishing a milestone for the development of domestically produced intracardiac echocardiography technology. In December of the same year, the accompanying TINGSN FINDERS 1 portable color ultrasound diagnostic system was approved, further enhancing the company’s intracardiac echocardiography product ecosystem. From "TINGSN Sonic Eyes 10" to "TINGSN Sonic Eyes 10 Pro" and then to "TINGSN Sonic Eyes 8 Eco," each new product launch reflects TINGSN's relentless pursuit of technological excellence and deep understanding of clinical needs. The continuously expanding intracardiac echocardiography product line will also better meet diverse clinical demands, providing doctors with more flexible options.

The approval of the first domestically produced 8F intracardiac echocardiography catheter marks a significant milestone in the development history of TINGSN. TINGSN will take this as a new starting point and continue to uphold the vision of "Using technology to safeguard health." The company will continuously increase R&D investment, optimize product performance, and promote the popularization and application of domestically produced intracardiac echocardiography technology. TINGSN will also further deepen its cooperation with clinical experts, focusing on clinical needs to develop more high-quality and efficient medical products. This will enable more patients with heart disease to benefit from the convenience and affordability offered by domestically produced high-end medical devices, injecting continuous momentum into the advancement of cardiovascular disease diagnosis and treatment in China!